These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9394623)

  • 61. [Study advancement of calpain and apoptosis following cerebral ischemia].
    Liu J; Xu J; Wang G; Yang M; Guo L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1150-3. PubMed ID: 19947509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Calpains (intracellular calcium-activated cysteine proteinases): structure-activity relationships and involvement in normal and abnormal cellular metabolism.
    Johnson P
    Int J Biochem; 1990; 22(8):811-22. PubMed ID: 2279616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of calpain-specific inactivators by screening of positional scanning epoxide libraries.
    Cuerrier D; Moldoveanu T; Campbell RL; Kelly J; Yoruk B; Verhelst SHL; Greenbaum D; Bogyo M; Davies PL
    J Biol Chem; 2007 Mar; 282(13):9600-9611. PubMed ID: 17218315
    [TBL] [Abstract][Full Text] [Related]  

  • 64. m-Calpain activation in vitro does not require autolysis or subunit dissociation.
    Chou JS; Impens F; Gevaert K; Davies PL
    Biochim Biophys Acta; 2011 Jul; 1814(7):864-72. PubMed ID: 21549862
    [TBL] [Abstract][Full Text] [Related]  

  • 65. All cut up! The consequences of calpain activation on platelet function.
    Randriamboavonjy V; Fleming I
    Vascul Pharmacol; 2012; 56(5-6):210-5. PubMed ID: 22386643
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1.
    Kim SY; Bae CD
    Exp Mol Med; 1998 Dec; 30(4):257-62. PubMed ID: 9894158
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation.
    Bukowska A; Lendeckel U; Bode-Böger SM; Goette A
    Cardiovasc Ther; 2012 Jun; 30(3):e115-27. PubMed ID: 21108772
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reversible activation of human neutrophil calpain promoted by interaction with plasma membranes.
    Pontremoli S; Sparatore B; Salamino F; Michetti M; Sacco O; Melloni E
    Biochem Int; 1985 Jul; 11(1):35-44. PubMed ID: 2994672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ca2+-dependent neutral proteinase from human erythrocytes: activation by Ca2+ ions and substrate and regulation by the endogenous inhibitor.
    Melloni E; Salamino F; Sparatore B; Michetti M; Pontremoli S
    Biochem Int; 1984 Apr; 8(4):477-89. PubMed ID: 6089826
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
    Gil-Parrado S; Assfalg-Machleidt I; Fiorino F; Deluca D; Pfeiler D; Schaschke N; Moroder L; Machleidt W
    Biol Chem; 2003 Mar; 384(3):395-402. PubMed ID: 12715890
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CaMPDB: a resource for calpain and modulatory proteolysis.
    duVerle D; Takigawa I; Ono Y; Sorimachi H; Mamitsuka H
    Genome Inform; 2010 Jan; 22():202-13. PubMed ID: 20238430
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of two recombinant Drosophila calpains. CALPA and a novel homolog, CALPB.
    Jékely G; Friedrich P
    J Biol Chem; 1999 Aug; 274(34):23893-900. PubMed ID: 10446155
    [TBL] [Abstract][Full Text] [Related]  

  • 73. S-nitrosation of calpains is associated with cardioprotection in myocardial I/R injury.
    Totzeck M; Korste S; Miinalainen I; Hendgen-Cotta UB; Rassaf T
    Nitric Oxide; 2017 Jul; 67():68-74. PubMed ID: 28392447
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Calpain regulates actin remodeling during cell spreading.
    Potter DA; Tirnauer JS; Janssen R; Croall DE; Hughes CN; Fiacco KA; Mier JW; Maki M; Herman IM
    J Cell Biol; 1998 May; 141(3):647-62. PubMed ID: 9566966
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Involvement of calpains in growth factor-mediated migration.
    Leloup L; Mazères G; Daury L; Cottin P; Brustis JJ
    Int J Biochem Cell Biol; 2006; 38(12):2049-63. PubMed ID: 16971167
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calcium-activated neutral proteases (calpains) are carbohydrate binding proteins.
    Zimmerman UJ; Schlaepfer WW
    J Biol Chem; 1988 Aug; 263(24):11609-12. PubMed ID: 2841330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Distinct substrate specificities and functional roles for the 78- and 76-kDa forms of mu-calpain in human platelets.
    Schoenwaelder SM; Kulkarni S; Salem HH; Imajoh-Ohmi S; Yamao-Harigaya W; Saido TC; Jackson SP
    J Biol Chem; 1997 Oct; 272(40):24876-84. PubMed ID: 9312088
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New m-calpain substrate-based azapeptide inhibitors.
    Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
    J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Implications of calpains in health and diseases.
    Chakraborti S; Alam MN; Paik D; Shaikh S; Chakraborti T
    Indian J Biochem Biophys; 2012 Oct; 49(5):316-28. PubMed ID: 23259318
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future?
    Miller DJ; Adams SE; Hallett MB; Allemann RK
    Future Med Chem; 2013 Nov; 5(17):2057-74. PubMed ID: 24215346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.